Free Trial

Centessa Pharmaceuticals (CNTA) Insider Trading & Ownership

Centessa Pharmaceuticals logo
$16.74 -0.09 (-0.53%)
(As of 11/20/2024 ET)

Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
11.59%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$5.86 M
Get CNTA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Centessa Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CNTA Insider Buying and Selling by Quarter

Centessa Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/25/2024Gregory M WeinhoffInsiderSell11,742$15.38$180,591.96  
10/23/2024Saurabh SahaCEOSell2,592$15.32$39,709.44  
10/21/2024Saurabh SahaCEOSell22,205$15.80$350,839.00  
9/25/2024Gregory M WeinhoffInsiderSell16,619$15.69$260,752.11  
9/20/2024Saurabh SahaCEOSell55,000$16.53$909,150.00  
9/10/2024Saurabh SahaCEOSell175,000$16.52$2,891,000.00  
9/9/2024Gregory M WeinhoffInsiderSell25,000$15.00$375,000.00  
8/22/2024Gregory M WeinhoffInsiderSell12,198$12.17$148,449.66  
8/22/2024Saurabh SahaCEOSell506$12.23$6,188.38  
8/20/2024Saurabh SahaCEOSell4,169$12.32$51,362.08  
3/25/2024Karen M AndersonInsiderSell51,160$11.88$607,780.80  
2/1/2024Harris RotmanSVPSell4,267$8.10$34,562.70  
(Data available from 1/1/2013 forward)

CNTA Insider Trading Activity - Frequently Asked Questions

The list of insiders at Centessa Pharmaceuticals includes Antoine Yver, David J Grainger, David M Chao, Gregory M Weinhoff, Harris Rotman, Iqbal J Hussain, Karen M Anderson, Medicxi Ventures Management (J, Rubertis Francesco De, Saurabh Saha, Thomas Templeman, and Tia L Bush. Learn more on insiders at CNTA.

11.59% of Centessa Pharmaceuticals stock is owned by insiders. Learn more on CNTA's insider holdings.

The following insiders have sold CNTA shares in the last 24 months: Antoine Yver ($117,899.60), Gregory M Weinhoff ($964,793.73), Harris Rotman ($270,337.06), Karen M Anderson ($607,780.80), Saurabh Saha ($4,248,248.90), and Tia L Bush ($35,840.00).

Insiders have sold a total of 455,612 Centessa Pharmaceuticals shares in the last 24 months for a total of $6,244,900.09 sold.

Centessa Pharmaceuticals Key Executives

  • Dr. Saurabh Saha M.D. (Age 48)
    Ph.D., CEO & Director
    Compensation: $1.04M
  • Dr. David M. Chao Ph.D. (Age 56)
    Chief Administrative Officer
    Compensation: $710.3k
  • Mr. John J. Crowley CPA (Age 50)
    CFO and Principal Financial & Accounting Officer
  • Ms. Tia L. Bush (Age 53)
    Chief Technology & Quality Officer
  • Ms. Kristen K. Sheppard Esq.
    J.D., Senior Vice President of Investor Relations & Corporate Communications
  • Mr. Iqbal J. Hussain L.L.B. (Age 43)
    General Counsel, Chief Compliance Officer & Corporate Secretary
  • Ms. Karen M. Anderson (Age 56)
    Chief People Officer
  • Dr. Gregory M. Weinhoff M.B.A. (Age 53)
    M.D., Chief Business Officer
    Compensation: $655k
  • Dr. Mario Alberto Accardi Ph.D.
    President of the Orexin Program
  • Ms. April Dovholuk
    Senior Vice President of Development Operations


This page (NASDAQ:CNTA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners